Concepedia

Reina Natero

RN

Statistics

Publications

11

Citations

441

H-Index

11

Active since

1998

Affiliations

Bayer (United States)(Current)

Florida International University

Bayer (Germany)

Carolina Veterinary Specialists

Reina Natero is an author at Bayer (United States) specializing in medicinal chemistry, pharmacology, and drug discovery.

Publications per year

1998–2011

11

Publications

11

A Scaleable Synthesis of BAY 43-9006:  A Potent Raf Kinase Inhibitor for the Treatment of Cancer

Donald Bankston, Jacques Dumas, Reina Natero et al. · Organic Process Research & Development · 2002 · 112 citations

, , +11

An optimal redox status for the survival of axotomized ganglion cells in the developing retina

Vincent Castagné, Karine Lefèvre, Reina Natero et al. · Neuroscience · 1999 · 79 citations

, , +16

1-Phenyl-5-pyrazolyl ureas: potent and selective p38 kinase inhibitors

Jacques Dumas, Holia Hatoum‐Mokdad, Robert Sibley et al. · Bioorganic & Medicinal Chemistry Letters · 2000 · 53 citations · Full text

, , +7

Omega-carboxypyridyl substituted ureas as Raf kinase inhibitors

Uday R. Khire, Donald Bankston, J A Barbosa et al. · Bioorganic & Medicinal Chemistry Letters · 2003 · 44 citations · Full text

, , +9

CVT-4325: a potent fatty acid oxidation inhibitor with favorable oral bioavailability

Elfatih Elzein, Prabha N. Ibrahim, Dmitry O. Koltun et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 33 citations · Full text

, , +13

1–5 of 11